Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Clinical trial NCT04323202 · COMPLETED
Trial details
- NCT number
- NCT04323202
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2024-07-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.